Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Loading network data...

Showing 5 of 5 trials

Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

Role: collaborator

Non-Expert Acquisition & Remote Expert Review of Screening Echocardiography Images From Child Health & AnteNatal Clinics

Role: collaborator

Immunisation for Adolescents Against Serious Communicable Diseases (B Part of it NT)

Role: collaborator

The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease

Role: collaborator

AIMHI NT Relapse Prevention Trial

Role: collaborator

All 5 trials loaded